Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?

Abstract

In the Euro Heart Survey, paroxysmal AF had a comparable risk for thrombo-embolic events as persistent and permanent AF. This observation strengthens the guideline recommendation not to consider the clinical AF subtype when deciding on anticoagulation.